Cleared Traditional

K822982 - MIDAS 100 HEMACOLOR STAIN #66030

K822982 is the FDA 510(k) clearance for MIDAS 100 HEMACOLOR STAIN #66030 by Emd Chemicals, Inc.. It is a Class 1 Hematology device (product code HYB) cleared through the Traditional 510(k) pathway after a 19-day FDA review.

K822982 · Emd Chemicals, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1982
Decision
19d
Days
Class 1
Risk

K822982 is an FDA 510(k) clearance for the MIDAS 100 HEMACOLOR STAIN #66030. Classified as Eosin Y (product code HYB), Class I - General Controls.

Submitted by Emd Chemicals, Inc. (Mchenry, US). The FDA issued a Cleared decision on October 27, 1982 after a review of 19 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.1850 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Emd Chemicals, Inc. devices

Submission Details

510(k) Number K822982 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 08, 1982
Decision Date October 27, 1982
Days to Decision 19 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d faster than avg
Panel avg: 113d · This submission: 19d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HYB Eosin Y
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.1850
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.